Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0348321 (Haemophilus)
 15,372 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Bordetella bronchiseptica is primarily resistant against nitrofurantoin (MIC greater than 200 mug/ml), and this feature can be used for the differentiation of the organism from other gram-negative coccobacteria. Nitrofurantoin paper disks (300 mug) failed to affect the growth of 150 strains of B. bronchiseptica isolated from different animal hosts, but they produced marked inhibition zones in the cultures of the followingspecies: Pasteurella multocida, Pasteurella pneumotropica, Pasteurella haemolytica, Yersinia pseudotuberculosis, Yersinia enterocolitica, Francisella tularensis, Haemophilus influenzae, Haemophilus parainfluenzae, Brucella abortus, Brucella melitensis, Brucella suis and Brucella neotomae.
 ...
PMID:[Nitrofurantoin-test for the differentiation of bordetella bronchiseptica (author's transl)]. 80 44

The in vitro susceptibility of recent clinical isolates of Haemophilus equigenitalis to various antimicrobial agents was determined by the disk diffusion test and the World Health Organization-International Collaborative Study agar dilution procedure. Ampicillin and tetracycline were the most active drugs. All strains were susceptible to beta-lactam antibiotics, chloramphenicol, trimethoprim-sulfamethoxazole, nalidixic acid, nitrofurantoin (Furadantin), and bacitracin. All but two strains were resistant to streptomycin, whereas all strains were susceptible to the other aminocyclitol antibodies. All strains were resistant to clindamycin, lincomycin, and metronidazole.
 ...
PMID:In vitro susceptibility of Haemophilus equigenitalis, the causative organism of contagious equine metritis 1977, to antimicrobial agents. 719 84